|
1
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI
|
|
2
|
Deyrup AT: Epstein-Barr virus-associated
epithelial and mesenchymal neoplasms. Hum Pathol. 39:473–483. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shibata D and Weiss LM: Epstein-Barr
virus-associated gastric adenocarcinoma. Am J Pathol. 140:769–774.
1992.PubMed/NCBI
|
|
4
|
Tokunaga M, Land CE, Uemura Y, Tokudome T,
Tanaka S and Sato E: Epstein-Barr virus in gastric carcinoma. Am J
Pathol. 143:1250–1254. 1993.PubMed/NCBI
|
|
5
|
Murphy G, Pfeiffer R, Camargo MC and
Rabkin CS: Meta-analysis shows that prevalence of Epstein-Barr
virus-positive gastric cancer differs based on sex and anatomic
location. Gastroenterology. 137:824–833. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
7
|
Fukayama M and Ushiku T: Epstein-Barr
virus-associated gastric carcinoma. Pathol Res Pract. 207:529–537.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tokunaga M, Uemura Y, Tokudome T, et al:
Epstein-Barr virus related gastric cancer in Japan: a molecular
patho-epidemiological study. Acta Pathol Jpn. 43:574–581.
1993.PubMed/NCBI
|
|
9
|
van Beek J, zur Hausen A, Snel SN, et al:
Morphological evidence of an activated cytotoxic T-cell infiltrate
in EBV-positive gastric carcinoma preventing lymph node metastases.
Am J Surg Pathol. 30:59–65. 2006.PubMed/NCBI
|
|
10
|
Watanabe H, Enjoji M and Imai T: Gastric
carcinoma with lymphoid stroma. Its morphologic characteristics and
prognostic correlations. Cancer. 38:232–243. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song HJ, Srivastava A, Lee J, et al: Host
inflammatory response predicts survival of patients with
Epstein-Barr virus-associated gastric carcinoma. Gastroenterology.
139:84–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Beek J, zur Hausen A, Klein Kranenbarg
E, et al: EBV-positive gastric adenocarcinomas: a distinct
clinicopathologic entity with a low frequency of lymph node
involvement. J Clin Oncol. 22:664–670. 2004.PubMed/NCBI
|
|
13
|
Park ES, Do IG, Park CK, et al:
Cyclooxygenase-2 is an independent prognostic factor in gastric
carcinoma patients receiving adjuvant chemotherapy and is not
associated with EBV infection. Clin Cancer Res. 15:291–298. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang MS, Lee HS, Kim CW, Kim YI and Kim
WH: Clinicopathologic characteristics of Epstein-Barr
virus-incorporated gastric cancers in Korea. Pathol Res Pract.
197:395–400. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kijima Y, Ishigami S, Hokita S, Koriyama
C, Akiba S, Eizuru Y and Aikou T: The comparison of the prognosis
between Epstein-Barr virus (EBV)-positive gastric carcinomas and
EBV-negative ones. Cancer Lett. 200:33–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shibata D, Tokunaga M, Uemura Y, Sato E,
Tanaka S and Weiss LM: Association of Epstein-Barr virus with
undifferentiated gastric carcinomas with intense lymphoid
infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol.
139:469–474. 1991.PubMed/NCBI
|
|
17
|
Lauwers GY, Carneiro F, Graham DY, et al:
Gastric carcinoma. WHO Classification of Tumours of the Digestive
System. Bosman FT, Carneiro F, Hruban RH and Theise ND: IARC; Lyon:
pp. 48–58. 2010
|
|
18
|
Hofmann M, Stoss O, Shi D, et al:
Assessment of a HER2 scoring system for gastric cancer: results
from a validation study. Histopathology. 52:797–805. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang CC, Chen ML, Hsu KH, et al: Second
malignant tumors in patients with nasopharyngeal carcinoma and
their association with Epstein-Barr virus. Int J Cancer.
87:228–231. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Minamoto T, Mai M, Watanabe K, et al:
Medullary carcinoma with lymphocytic infiltration of the stomach.
Clinicopathologic study of 27 cases and immunohistochemical
analysis of the subpopulations of infiltrating lymphocytes in the
tumor. Cancer. 66:945–952. 1990. View Article : Google Scholar
|
|
21
|
Haas M, Büttner M, Rau TT, Fietkau R,
Grabenbauer GG and Distel LV: Inflammation in gastric
adenocarcinoma of the cardia: how do EBV infection, Her2
amplification and cancer progression influence tumor-infiltrating
lymphocytes? Virchows Arch. 458:403–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grogg KL, Lohse CM, Pankratz VS, Halling
KC and Smyrk TC: Lymphocyte-rich gastric cancer: associations with
Epstein-Barr virus, microsatellite instability, histology, and
survival. Mod Pathol. 16:641–651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yokota T, Ishiyama S, Saito T, et al: Is
tumor size a prognostic indicator for gastric carcinoma? Anticancer
Res. 22:3673–3677. 2002.PubMed/NCBI
|
|
24
|
Edge SB, Byrd DR, Compton CC, Fritz AG, et
al: AJCC Cancer Staging Manual. 7th edition. Springer; New York,
NY: pp. 117–126. 2010
|
|
25
|
Saito H, Osaki T, Murakami D, et al:
Macroscopic tumor size as a simple prognostic indicator in patients
with gastric cancer. Am J Surg. 192:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu J, Huang CM, Zheng CH, Li P, Xie JW,
Wang JB and Lin JX: Consideration of tumor size improves the
accuracy of TNM predictions in patients with gastric cancer after
curative gastrectomy. Surg Oncol. 22:167–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu DZ, Geng QR, Long ZJ, et al: Positive
lymph node ratio is an independent prognostic factor in gastric
cancer after d2 resection regardless of the examined number of
lymph nodes. Ann Surg Oncol. 16:319–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marchet A, Mocellin S, Ambrosi A, et al:
The ratio between metastatic and examined lymph nodes (N ratio) is
an independent prognostic factor in gastric cancer regardless of
the type of lymphadenectomy: results from an Italian multicentric
study in 1853 patients. Ann Surg. 245:543–552. 2007. View Article : Google Scholar
|
|
29
|
Persiani R, Rausei S, Antonacci V, Biondi
A, Casella F, Ciccoritti L and D’Ugo D: Metastatic lymph node
ratio: a new staging system for gastric cancer. World J Surg.
33:2106–2111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Inoue K, Nakane Y, Iiyama H, et al: The
superiority of ratio-based lymph node staging in gastric carcinoma.
Ann Surg Oncol. 9:27–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chong JM, Sakuma K, Sudo M, et al:
Interleukin-1β expression in human gastric carcinoma with
Epstein-Barr virus infection. J Virol. 76:6825–6831. 2002.
|
|
32
|
Lee HS, Chang MS, Yang HK, Lee BL and Kim
WH: Epstein-barr virus-positive gastric carcinoma has a distinct
protein expression profile in comparison with Epstein-barr
virus-negative carcinoma. Clin Cancer Res. 10:1698–1705. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
zur Hausen A, van Grieken NC, Meijer GA,
et al: Distinct chromosomal aberrations in Epstein-Barr
virus-carrying gastric carcinomas tested by comparative genomic
hybridization. Gastroenterology. 121:612–618. 2001.PubMed/NCBI
|
|
34
|
Chang MS, Uozaki H, Chong JM, et al: CpG
island methylation status in gastric carcinoma with and without
infection of Epstein-Barr virus. Clin Cancer Res. 12:2995–3002.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chong JM, Sakuma K, Sudo M, et al: Global
and non-random CpG-island methylation in gastric carcinoma
associated with Epstein-Barr virus. Cancer Sci. 94:76–80. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hino R, Uozaki H, Murakami N, et al:
Activation of DNA methyltransferase 1 by EBV latent membrane
protein 2A leads to promoter hypermethylation of PTEN gene
in gastric carcinoma. Cancer Res. 69:2766–2774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu DX, Tanhehco Y, Chen J, et al:
Bortezomib-induced enzyme-targeted radiation therapy in
herpesvirus-associated tumors. Nat Med. 14:1118–1122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jung EJ, Lee YM, Lee BL, Chang MS and Kim
WH: Lytic induction and apoptosis of Epstein-Barr virus-associated
gastric cancer cell line with epigenetic modifiers and ganciclovir.
Cancer Lett. 247:77–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsu JT, Chen TC, Tseng JH, et al: Impact
of HER-2 overexpression/amplification on the prognosis of gastric
cancer patients undergoing resection: a single-center study of
1,036 patients. Oncologist. 16:1706–1713. 2011. View Article : Google Scholar : PubMed/NCBI
|
